Gastroenterology & Hepatology drugs

62 results

  • aciphex

    (rabeprazole sodium)
    Woodward Pharma Services LLC
    ACIPHEX delayed-release tablets are indicated for the treatment and maintenance of erosive or ulcerative GERD, healing of duodenal ulcers, eradication of Helicobacter pylori to prevent ulcer recurrence, and long-term treatment of pathological hypersecretory conditions. It can also treat symptomatic GERD in adolescents aged 12 and older.

  • aemcolo

    (Rifamycin)
    RedHill Biopharma Ltd
    AEMCOLO is indicated for treating travelers' diarrhea caused by non-invasive strains of Escherichia coli in adults. It is not recommended for diarrhea with fever or bloody stools, or due to other pathogens. Use is limited to proven or strongly suspected infections to prevent drug resistance.

  • akynzeo

    (Netupitant and Palonosetron)
    Helsinn Therapeutics (U.S.), Inc.
    AKYNZEO is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing cancer chemotherapy, particularly highly emetogenic regimens. It is used in combination with dexamethasone and consists of palonosetron and netupitant (or fosnetupitant in the injection form).

  • albuked

    (Albumin (Human))
    KEDRION BIOPHARMA, INC.
    Albuked 25 is indicated for emergency treatment of hypovolemic shock, burn therapy, and as a treatment for hypoproteinemia, ARDS, acute liver failure, neonatal hemolytic disease, and acute nephrosis. It may also be used during cardiopulmonary bypass and renal dialysis to maintain blood volume and colloid osmotic pressure.

  • albuked

    (Albumin (Human))
    KEDRION BIOPHARMA, INC.
    Albuked 5 is indicated for the emergency treatment of hypovolemic shock, burn therapy, cardiopulmonary bypass, acute liver failure, and sequestration of protein-rich fluids. It aids in expanding circulating blood volume and maintaining colloid osmotic pressure in various clinical scenarios.

  • alvaiz

    (Eltrombopag)
    Teva Pharmaceuticals, Inc.
    ALVAIZ (eltrombopag) is indicated for treating thrombocytopenia in patients with persistent or chronic immune thrombocytopenia, chronic hepatitis C, and severe aplastic anemia who have not responded adequately to other therapies. It is not approved for myelodysplastic syndromes or with direct-acting antiviral agents for hepatitis C.

  • aponvie

    (APREPITANT)
    Heron Therapeutics, Inc.
    APONVIE is indicated for the prevention of postoperative nausea and vomiting (PONV) in adults. It has not been studied for treating established nausea and vomiting.

  • avastin

    (bevacizumab)
    Genentech, Inc.
    Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian or peritoneal cancers, often in combination with other chemotherapy agents.

  • avsola

    (infliximab-axxq)
    Amgen Inc
    AVSOLA is indicated for reducing signs and symptoms, inducing and maintaining remission in moderately to severely active Crohn's disease (adult and pediatric), ulcerative colitis (adult and pediatric), and other conditions like rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis.

  • avycaz

    (ceftazidime, avibactam)
    Allergan, Inc.
    AVYCAZ (ceftazidime and avibactam) is indicated for treating complicated intra-abdominal and urinary tract infections, including pyelonephritis, as well as hospital-acquired and ventilator-associated bacterial pneumonia. It targets susceptible gram-negative bacteria in adult and pediatric patients (≥31 weeks gestational age).